World's Best Scientists 2026 revealed!
Akira Yamada

Akira Yamada

D-Index & Metrics

Immunology

D-Index
57
Citations
8382
World Ranking
3656
National Ranking
143

Overview

Akira Yamada is affiliated with Kurume University in Japan. Their research focuses extensively on medicine, with significant contributions to biochemistry, genetics, molecular biology, immunology, and microbiology. Within these broader fields, Yamada's work concentrates on oncology, immunology, molecular biology, pulmonary and respiratory medicine, and cancer research.

The scientist's scholarly output includes numerous papers published in several peer-reviewed journals. Notable recent publications include:

  • Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries, 2021, Nature Communications
  • ENIGMA CHEK2 gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk, 2023, Clinical Cancer Research
  • Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial, 2020, Cancer Immunology Immunotherapy
  • Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer, 2020, Cancer Science
  • CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine-treated ovarian cancer patients, 2020, Cancer Science

Yamada collaborates regularly with several co-authors, who have published multiple papers together. Frequent collaborators include:

  • Kayoko Waki
  • Kyogo Itoh
  • Nobukazu Komatsu
  • Shigeki Shichijo
  • Kouichiro Kawano

The bulk of Yamada's publications appear in journals such as:

  • Cancer Science
  • Cancer Immunology Immunotherapy
  • Molecular and Clinical Oncology
  • Nature Communications
  • Clinical Cancer Research

The main subjects covered by Yamada's research include cancer immunotherapy and biomarkers, immunotherapy and immune responses, vaccines and immunoinformatics approaches, immune cells in cancer, cancer genomics and diagnostics, aortic disease and treatment approaches, and monoclonal and polyclonal antibodies research.

Overall, Akira Yamada's academic work focuses on molecular mechanisms and clinical applications within oncology and immunology, emphasizing cancer vaccines, immune responses, and genetic factors relevant to cancer risk and treatment outcomes.

Best Publications

  • Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese.

    T. Higuchi;N. Seki;S. Kamizono;A. Yamada

  • Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome.

    Yukiko Ohyama;Seiji Nakamura;Goro Matsuzaki;Masanori Shinohara

  • Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL.

    Masanobu Nakao;Shigeki Shichijo;Toshihiro Imaizumi;Yoshiko Inoue

  • Next‐generation peptide vaccines for advanced cancer

    Akira Yamada;Tetsuro Sasada;Masanori Noguchi;Kyogo Itoh

  • Immunologic Evaluation of Personalized Peptide Vaccination for Patients with Advanced Malignant Glioma

    Naoki Yajima;Ryuya Yamanaka;Takashi Mine;Naoto Tsuchiya

  • Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.

    Masanori Noguchi;Kazuhiko Kobayashi;Norie Suetsugu;Katsurou Tomiyasu

  • Induction of Cellular Immune Responses to Tumor Cells and Peptides in Colorectal Cancer Patients by Vaccination with SART3 Peptides

    Yoshiaki Miyagi;Nobue Imai;Teruo Sasatomi;Akira Yamada

  • Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.

    Takashi Mine;Yuji Sato;Masanori Noguchi;Teruo Sasatomi

  • Diagnostic skin test reactions with varicella virus antigen and clinical application of the test.

    Hitoshi Kamiya;Toshiaki Ihara;Akihiko Hattori;Toshiaki Iwasa

  • A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.

    Masanori Noguchi;Tatsuyuki Kakuma;Hirotsugu Uemura;Yasutomo Nasu

  • Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy

    Koichi Azuma;Yoshihiro Komohara;Tetsuro Sasada;Yasuhiro Terazaki

  • Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen–A24 With Recurrent or Progressive Glioblastoma Multiforme

    Mizuhiko Terasaki;Soichiro Shibui;Yoshitaka Narita;Takamitsu Fujimaki

  • Personalized peptide vaccines: a new therapeutic modality for cancer.

    Kyogo Itoh;Akira Yamada

  • Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel

    Koichi Azuma;Tetsuro Sasada;Akihiko Kawahara;Sinzo Takamori

  • Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases.

    Nanae Harashima;Koji Tanaka;Teruo Sasatomi;Kanako Shimizu

  • PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer

    Kayoko Waki;Teppei Yamada;Koichi Yoshiyama;Yasuhiro Terazaki

  • A novel glycoprotein obtained from Chlorella vulgaris strain CK22 shows antimetastatic immunopotentiation.

    Kuniaki Tanaka;Akira Yamada;Kiyoshi Noda;Takashi Hasegawa

  • A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer

    Kazuhiro Yoshimura;Takafumi Minami;Masahiro Nozawa;Takahiro Kimura

  • Molecular Cloning of a Glycosylphosphatidylinositol-Anchored Molecule CDw108

    Akira Yamada;Keisuke Kubo;Toshikazu Takeshita;Nanae Harashima

  • Vaccination with predesignated or evidence-based peptides for patients with recurrent gynecologic cancers.

    Naotake Tsuda;Kazuo Mochizuki;Mamoru Harada;Aki Sukehiro

  • Tissue-specific distribution and age-dependent increase of human CD11b+ T cells.

    T Hoshino;A Yamada;J Honda;Y Imai

  • Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients.

    Takashi Mine;Rumi Gouhara;Naoya Hida;Nobue Imai

Frequent Co-Authors

Kyogo Itoh
Kyogo Itoh Kurume University
Michio Sata
Michio Sata Kurume University
Kikuo Nomoto
Kikuo Nomoto Kyushu University
Seiji Naito
Seiji Naito Kyushu University
Satoru Todo
Satoru Todo Hokkaido University
Yasunobu Yoshikai
Yasunobu Yoshikai Kyushu University
Yukihiro Shoyama
Yukihiro Shoyama Nagasaki International University
Nobuoki Kohno
Nobuoki Kohno Hiroshima University
Atsushi Natsume
Atsushi Natsume Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related advanced nursing degrees can open diverse career opportunities in healthcare research and patient care. Many professionals transition from roles such as Family Nurse Practitioners to more specialized fields through programs like the fnp to acnp bridge program online, which offers a streamlined path to acute care specialization.

Students eager to enter clinical practice quickly might explore accelerated fnp programs. These programs balance rigorous coursework with online flexibility, ideal for those seeking fast-paced advancement while managing other commitments.

For individuals without a nursing background but interested in nursing careers that intersect with immunological sciences, online accelerated nursing programs for non nurses provide accessible entry points into the profession, allowing a quicker transition into healthcare roles.

Additionally, the easiest absn to get into options cater to those seeking reasonably attainable admissions criteria without compromising quality, making them ideal for busy learners focusing on foundational nursing education as a stepping stone towards immunology-related careers.

Best Scientists Citing Akira Yamada

Trending Scientists